NCT00265148 Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00257673 Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00246896 Care Management for Patients With Alzheimer Disease and Their Family Caregivers Status COMPLETED Phase NA
NCT00244322 Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00241293 Influence of Age on Hemispheric Lateralization of Language : a Longitudinal Study Status COMPLETED Phase N/A
NCT00239759 MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology Status COMPLETED Phase N/A
NCT00235716 A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00234637 Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment Status COMPLETED Phase PHASE4
NCT00231946 ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) Status COMPLETED Phase PHASE3
NCT00230568 EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) Status COMPLETED Phase PHASE4
NCT00224497 A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00219232 An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease Status COMPLETED Phase PHASE3
NCT00217763 European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients Status UNKNOWN Phase PHASE3